Professor Guido Franzoso
Centre Co-Director, Chair in Inflammation & Signal Transduction
Faculty of Medicine, Department of Immunology and Inflammation
Professor Guido Franzoso's inventions
First-in-class drug candidate for treatment of multiple myeloma and Diffuse Large B Cell Lymphoma
DTP3 is a first-in-class GADD45β/MKK7 inhibitor targeting the NF-κB pathway Further information on this technology
Sign up for updates
Sign up for monthly technology alerts via email, and find other ways to connect with us.